Mathematical analyses of two-compartment model of human cholesterol circulatory transport in application to high blood cholesterol prevention, diagnosis and treatment

Cholesterol plays a vital role in human body and thus its unbalanced homeostasis leads to health problems. Elevated blood cholesterol levels are now considered a classic coronary risk factor and are suspected to lead to coronary artery diseases, causing 2.6 millions of deaths each year. However, many of the mechanisms behind cholesterol-related processes remain unknown. Mathematical and computational models can aid investigation of complex biological phenomena, yet cholesterol-focused models remain rare. Here, we develop a two-compartment mathematical model to investigate cholesterol transport in the human circulatory system. We focus on the key aspects of cholesterol circulatory transport in the lipoproteins, its de novo synthesis and bile recycling and represent them by two simultaneous linear differential equations. The solutions yield changes over time of the cholesterol levels in the liver (compartment I) and bloodstream (compartment II). Drawing from the current clinical practice, we show the application of the model to personalized high blood cholesterol prevention, diagnosis and treatment.

[1]  Yang Kuang,et al.  Mathematical models and software tools for the glucose-insulin regulatory system and diabetes: an overview , 2006 .

[2]  M. Edidin The state of lipid rafts: from model membranes to cells. , 2003, Annual review of biophysics and biomolecular structure.

[3]  F. Maxfield,et al.  Cholesterol, the central lipid of mammalian cells. , 2010, Current opinion in cell biology.

[5]  EDWIN C. Webb The Enzymes , 1961, Nature.

[6]  M. Eriksson,et al.  Influence of age on the metabolism of plasma low density lipoproteins in healthy males. , 1991, The Journal of clinical investigation.

[7]  Bruce Alberts,et al.  Essential Cell Biology , 1983 .

[8]  Dejan Nickovic,et al.  On Temporal Logic and Signal Processing , 2012, ATVA.

[9]  U. Laaser,et al.  Treatment of elevated cholesterol in a representative cross-sectional sample of 4,892 Germans: is there a social gradient? , 2013 .

[10]  Olga Hrydziuszko,et al.  Mathematical Two-compartment Model of Human Cholesterol Transport in Application to High Blood Cholesterol Diagnosis and Treatment , 2014, CS2Bio.

[11]  L. Finkelstein,et al.  Mathematical model of the human renal system , 1985, Medical and Biological Engineering and Computing.

[12]  François Rechenmann,et al.  Genetic network analyzer: a tool for the qualitative modeling and simulation of bacterial regulatory networks. , 2012, Methods in molecular biology.

[13]  M. Linton,et al.  Current perspectives on statins. , 2000, Circulation.

[14]  A. Globerson,et al.  Correlations between membrane viscosity, serum cholesterol, lymphocyte activation and aging in man , 1980, Mechanisms of Ageing and Development.

[15]  R. Collins,et al.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2005, The Lancet.

[16]  G. Gimpl,et al.  Regulation of receptor function by cholesterol , 2000, Cellular and Molecular Life Sciences CMLS.

[17]  J. Malagelada,et al.  Bile acid secretion and biliary bile acid composition altered by cholecystectomy , 1973, The American Journal of Digestive Diseases.

[18]  D. Russell The enzymes, regulation, and genetics of bile acid synthesis. , 2003, Annual review of biochemistry.

[19]  Robert A Hegele,et al.  The end of the road for CETP inhibitors after torcetrapib? , 2009, Current opinion in cardiology.

[20]  S. Mcphee,et al.  Current Medical Diagnosis & Treatment , 1993 .

[21]  P. Libby,et al.  Progress and challenges in translating the biology of atherosclerosis , 2011, Nature.

[22]  安井 多喜雄,et al.  α-cholesterol の臨床的意義 , 1980 .

[23]  F. Berr,et al.  Effects of cholecystectomy on the kinetics of primary and secondary bile acids. , 1989, The Journal of clinical investigation.

[24]  M. Kates Biochemistry of Lipids.T. W. Goodwin , 1976 .

[25]  Hidde de Jong,et al.  Modeling and Simulation of Genetic Regulatory Systems: A Literature Review , 2002, J. Comput. Biol..

[26]  N. Ridgway,et al.  Biochemistry of lipids, lipoproteins and membranes , 2015 .

[27]  Zhihua Jiang,et al.  Lipoproteins, cholesterol homeostasis and cardiac health , 2009, International journal of biological sciences.

[28]  D. Shoback,et al.  Greenspan's Basic & Clinical Endocrinology , 2007 .

[29]  R. Collins,et al.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2005, The Lancet.

[30]  D. Kritchevsky,et al.  Bile acid metabolism and fiber. , 1978, The American journal of clinical nutrition.

[31]  J A Sherratt,et al.  Lipoprotein oxidation and its significance for atherosclerosis: A mathematical approach , 2002, Bulletin of mathematical biology.

[32]  C. Beckers,et al.  Increase in choleresis by means of artichoke extract. , 1994, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[33]  S. Grundy The issue of statin safety: where do we stand? , 2005, Circulation.

[34]  W. Okamura,et al.  Synthesis of Vitamin D (Calciferol) , 1995 .

[35]  T. Pedley,et al.  Alteration of mean wall shear stress near an oscillating stagnation point. , 1998, Journal of biomechanical engineering.

[36]  A. Groen,et al.  Regulation of cholesterol homeostasis , 2013, Molecular and Cellular Endocrinology.

[37]  E. Ikonen,et al.  Functional rafts in cell membranes , 1997, Nature.

[38]  P. Yeagle Cholesterol and the cell membrane. , 1985, Biochimica et biophysica acta.

[39]  F. Young Biochemistry , 1955, The Indian Medical Gazette.

[40]  S. Boekholdt,et al.  Role of CETP inhibitors in the treatment of dyslipidemia , 2004, Current opinion in lipidology.